Jakobsen, JC, Katakam, KK, Schou, A
et al. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry
Hieronymus, F, Lisinski, A, Näslund, J, Eriksson, E. Multiple possible inaccuracies cast doubt on a recent report suggesting selective serotonin reuptake inhibitors to be toxic and ineffective. Acta Neuropsychiatr
Wernicke, J, Dunlop, SR, Dornseif, BE, Zerbe, R. Fixed-dose fluoxetine therapy for depression. Psychopharmacol Bull
Wernicke, JF, Dunlop, SR, Dornseif, B, Bosomworth, J, Humbert, M. Low-dose fluoxetine therapy for depression. Psychopharmacol Bull
Byerley, WF, Reimherr, FW, Wood, DR, Grosser, BI. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression. J Clin Psychopharmacol
Claghorn, JL, Earl, CQ, Walczak, DD
et al. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients. J Clin Psychopharmacol
Cohn, J, Wilcox, C. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder. J Clin Psychiatry
Coleman, CC, Cunningham, LA, Foster, VJ
et al. Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment. Ann Clin Psychiatry
Goldstein, DJ, Lu, Y, Detke, MJ, Wiltse, C, Mallinckrodt, C, Demitrack, MA. Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine. J Clin Psychopharmacol
Itil, T, Shrivastava, R, Mukherjee, S, Coleman, B, Michael, S. A double‐blind placebo‐controlled study of fluvoxamine and imipramine in out‐patients with primary depression. Br J Clin Pharmacol
Olie, J, Gunn, K, Katz, E. A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of major depression. Eur Psychiatry
Sramek, JJ, Kashkin, K, Jasinsky, O, Kardatzke, D, Kennedy, S, Cutler, NR. Placebo-controlled study of ABT-200 versus fluoxetine in the treatment of major depressive disorder. Depression
Kranzler, HR, Mueller, T, Cornelius, J
et al. Sertraline treatment of co-occurring alcohol dependence and major depression. J Clin Psychopharmacol
Pettinati, HM, Oslin, DW, Kampman, KM
et al. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry
Ravindran, A, Teehan, M, Bakish, D
et al. The impact of sertraline, desipramine, and placebo on psychomotor functioning in depression. Hum Psychopharmacol
Nyth, A, Gottfries, C, Lyby, K
et al. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr Scand
Kasper, S, de Swart, H, Andersen, HF. Escitalopram in the treatment of depressed elderly patients. Am J Geriatr Psychiatry
37. Forest Laboratories Inc: Study no. SCT-MD-01, Unpublished Data, Study report from U.S. Food and Drug Administration.
42. Forest Laboratories Inc. Scientific result summary –SCT-MD-27.
Rapaport, MH, Lydiard, RB, Pitts, CD
et al. Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial. J Clin Psychiatry
Schneider, LS, Nelson, JC, Clary, CM
et al. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry
Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St John’s wort) in major depressive disorder: a randomized controlled trial. JAMA
Coleman, CC, King, BR, Bolden-Watson, C
et al. A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Ther
Feighner, JP, Boyer, W. Paroxetine in the treatment of depression: a comparison with imipramine and placebo. Acta Psychiatr Scand
Lepola, UM, Loft, H, Reines, EH. Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo‐controlled study in depression in primary care. Int Clin Psychopharmacol
Rapaport, MH, Schneider, LS, Dunner, DL, Davies, JT, Pitts, CD. Efficacy of controlled-release paroxetine in the treatment of late-life depression. J Clin Psychiatry
Rickels, K, Amsterdam, J, Clary, C, Fox, I, Schweizer, E, Weise, C. The efficacy and safety of paroxetine compared with placebo in outpatients with major depression. J Clin Psychiatry. 1992;53(Suppl):30–32.
Sweeting, MJ, Sutton, AJ, Lambert, PC. What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data. Stat Med
Kuss, O. Statistical methods for meta‐analyses including information from studies without any events—add nothing to nothing and succeed nevertheless. Stat Med
Sharma, T, Gøtzsche, PC, Kuss, O. The Yusuf-Peto method was not a robust method for meta-analyses of rare events data from antidepressant trials. J Clin Epidemiol
Jakobsen, JC, Lindschou, J, Hellmuth, S, Schou, A, Krogh, J, Gluud, C. The effects of selective serotonin reuptake inhibitors versus no intervention, placebo, or ‘active’ placebo in patients with major depressive disorder. A systematic review of randomised clinical trials with meta-analyses and trial sequential analyses. PROSPERO, 2013:CRD42013004420. Available at http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42013004420. Accessed October 27, 2017.
Higuchi, T, Hong, JP, Jung, HY, Watanabe, Y, Kunitomi, T, Kamijima, K. Paroxetine controlled‐release formulation in the treatment of major depressive disorder: a randomized, double‐blind, placebo‐controlled study in Japan and Korea. Psychiatry Clin Neurosci
Garattini, S, Jakobsen, JC, Wetterslev, J
et al. Evidence-based clinical practice: overview of threats to the validity of evidence and how to minimise them. Eur J Intern Med
Ball, WA, Snavely, DB, Hargreaves, RJ, Szegedi, A, Lines, C, Reines, SA. Addition of an Nk1 receptor antagonist to an SSRI did not enhance the antidepressant effects of SSRI monotherapy: results from a randomized clinical trial in patients with major depressive disorder. Hum Psychopharmacol
Loo, H, Hale, A, D’haenen, H. Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. Int Clin Psychopharmacol
69. The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark. Review Manager (RevMan) 5.3., 2014.
StataCorp. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC, 2017.
Østergaard, SD. Do not blame the SSRIs: blame the Hamilton Depression Rating Scale. Acta Neuropsychiatr
Hooper, CL, Bakish, D. An examination of the sensitivity of the six-item Hamilton Rating Scale for Depression in a sample of patients suffering from major depressive disorder. J Psychiatry Neurosci
O’Sullivan, RL, Fava, M, Agustin, C, Baer, L, Rosenbaum, J. Sensitivity of the six‐item Hamilton Depression Rating Scale. Acta Psychiatr Scand
Gluud, C, Brok, J, Gong, Y, Koretz, RL. Hepatology may have problems with putative surrogate outcome measures. J Hepatol
Ragland, DR. Dichotomizing continuous outcome variables: dependence of the magnitude of association and statistical power on the cutpoint. Epidemiology
Dawson, NV, Weiss, R. Dichotomizing continuous variables in statistical analysis. A practice to avoid. Med Decis Making
Altman, DG, Royston, P. The cost of dichotomising continuous variables. BMJ.
Kirsch, I, Moncrieff, J. Clinical trials and the response rate illusion. Contemp Clin Trials
Fabre, LF. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients. J Clin Psychiatry, 1992;53(Suppl):40–43.
Nørby, ET. Svar til spørgsmål nr. 1056 (Alm. del) til sundhedsministeren fra Folketingets Sundheds- og Ældreudvalg den 18. juli 2017. Sagsnr.: 1705343. Dok. nr.: 416878. [Answer to question no. 1056 (general part) to the Minister of Health from the Committee on Health and Elderly the 28th of July, 2017. Case no. 1705343. Dokument no. 416878. Available at http://www.ft.dk/samling/20161/almdel/suu/spm/1056/index.htm. Accessed October 27, 2017.